Thomas Oellerich

Ruggenmergsaandoening na CAR-T-celtherapie met axicabtagene ciloleucel bij hooggradig B-cellymfoom

Efficacy and safety of immune checkpoint inhibition combined with concurrent chemoradiotherapy in patiënten met stage...